AstraZeneca PLC (AZN)
NYSE · Healthcare · Drug Manufacturers - General
AstraZeneca PLC is a Healthcare company with a market capitalization of $292.20B, a trailing P/E ratio of 28.4, and a dividend yield of 1.72%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 29, 2026 | $1.29 | $1.27 | +1.4% |
| Q3 2025 | November 6, 2025 | $1.19 | $1.13 | +4.9% |
| Q2 2025 | July 29, 2025 | $1.09 | $1.46 | -25.9% |
| Q1 2025 | April 29, 2025 | $1.25 | $1.12 | +11.6% |
| Q4 2024 | February 6, 2025 | $1.05 | $1.04 | +0.8% |
| Q3 2024 | November 12, 2024 | $0.91 | — | — |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is AstraZeneca PLC's market cap?
As of June 29, 2026, AstraZeneca PLC (AZN) has a market capitalization of $292.20B.
What is AstraZeneca PLC's P/E ratio?
AstraZeneca PLC trades at a trailing price-to-earnings (P/E) ratio of 28.4. Its forward P/E is 17.9.
Does AstraZeneca PLC pay a dividend?
Yes — AstraZeneca PLC pays a dividend yielding 1.72%, an annual payout of $3.20 per share.
What sector is AZN in?
AstraZeneca PLC is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What was AstraZeneca PLC's revenue?
In its latest reported fiscal year (ending December 31, 2025), AstraZeneca PLC reported revenue of $58.74B and net income of $10.26B.
Ask your own questions about AZN
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.